Skip to Content

Helping Doctors identify Minimal Hepatic Encephalopathy Quickly & Efficiently in busy practices!

Gift HE patients an Early Reversal & an Improved Quality of Life

Schedule a Call ›
HepaBuddy hero
Early, painless MHE screening that fits into a routine OPD visit.

Conventional screening tools like PHES & etc are:

Tools like the Psychometric Hepatic Encephalopathy Score (PHES) are crucial for diagnosing and managing hepatic encephalopathy, enabling early detection and effective treatment.

📄

Language & Literacy Dependent

⏱️

Time Consuming & Subjective

📈

Having Related Learning Effects

👤

Requires Trained Staff

Screen COVERT Hepatic Encephalopathy pre-emptively,
Even before clinical symptoms manifest

HepaBuddy clinical screening
🧠 Catch the early decline in mental cognition
🏥 Prompt Management & Reduce days of Hospitalisation
⚠️ Reduce risk & incidence of Falls

Helping Doctors Detect Hepatic Encephalopathy Early!

Scientifically Validated No Language Dependency Precise & Quick No Learning Effects
Download Catalog ›

Objectively assess MHE in your Busy OPD:

👤Requires no skilled staff
📦Compact Device: Portable
⏱️Test Time 2 minutes
🚫No Logistical Challenges
🚪No Specific Room required

HepaBuddy Device:

High Accuracy

High Specificity

High Reproducibility

HepaBuddy Dashboard

🖨️Generate & Print Reports
📊Historic Patterns for HE Episodes
🔒Enterprise Level Security
ABHA Compliant
HepaBuddy Dashboard

Easily set up HepaBuddy @your OPD/ Hospital

Download Catalog ›

Helping Doctors improve HE Management

Screen Patients to rule out MHE


  • Detecting changes in CFF scores from last visit
  • Compliance & Adherence to Prescription (Medicines, Diet & Advice)
  • Check Treatment Effectiveness
  • Adjust Medicine Dosage
  • Adjust Diet

Assessing Therapy Efficacy


  • Early Trigger Detection & Timely Intervention for:
  • Non GI / Systemic Infections
  • Dehydration, or Medication Side Effects
  • Check for Extrahepatic Causes
  • Electrolyte Imbalance
  • Diuretic Overdose
  • GI Bleeding
  • Use of Unproven Alternative Therapies

HepaBuddy: Improving Compliance & Outcomes

Mass screening at peripheral centers

Mass screening at Peripheral or Referral Centers

Patient waiting for transplant

Patient waiting for Transplant

Hear from the Experts:

Dr

The device has been tested on 60+ patients and a control group at Global Hospitals, which helped identify patients in MHE even before clinical symptoms could manifest, allowing early action. It has profound potential in clinical and non-clinical markets such as drivers, heavy machinery operators, and other complex occupations. The patient version is especially exciting, as it's being studied in trials led at Nanavati.

Clinical Investigator — Nanavati trial
Add your 2nd expert testimonial here
Add your 3rd expert testimonial here